Triepels R H, Van Den Heuvel L P, Trijbels J M, Smeitink J A
Nijmegen Center for Mitochondrial Disorders, University Medical Center Nijmegen, The Netherlands.
Am J Med Genet. 2001 Spring;106(1):37-45. doi: 10.1002/ajmg.1397.
Oxidative phosphorylation disorders make a contribution of 1 per 10,000 live births in man, of which isolated complex I deficiency is frequently the cause. Complex I, or NADH:ubiquinone oxidoreductase, is the largest multi-protein enzyme complex of the mitochondrial electron transfer chain. In complex I deficiency, various clinical phenotypes have been recognized, often resulting in multi-system disorders with a fatal outcome at a young age. Recent advances in complex I deficiency, regarding clinical, biochemical, and molecular aspects are described. However, the genetic causes of about 60% of complex I deficiency remain unclear. As a consequence, further research will be needed to clarify the genetic defects in the remaining cases. Novel strategies in which interesting non-structural nuclear-encoded disease-causing genes may be found, as well as the molecular genetic composition of human complex I, are presented.
氧化磷酸化障碍在人类活产中的发生率为万分之一,其中孤立性复合体I缺乏症是常见病因。复合体I,即NADH:泛醌氧化还原酶,是线粒体电子传递链中最大的多蛋白酶复合体。在复合体I缺乏症中,已识别出多种临床表型,常导致多系统疾病,并在年轻时出现致命后果。本文描述了复合体I缺乏症在临床、生化和分子方面的最新进展。然而,约60%的复合体I缺乏症的遗传病因仍不清楚。因此,需要进一步研究以阐明其余病例中的基因缺陷。本文还介绍了可能发现有趣的非结构性核编码致病基因的新策略,以及人类复合体I的分子遗传组成。